GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

GSK PLC closed 22.73% below its 52-week high of £18.24, which the company reached on May 16th.

GSK's Q1 2025 earnings will reveal progress in specialty medicines amid regulatory headwinds. Learn what to watch when the ...

Some justices may be skeptical of a bid by GSK, Pfizer and others to overturn ruling allowing lawsuits to proceed over claims ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a ...

Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...